THOXF - BioPorto A/S

Other OTC - Other OTC Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
27,086
28,969
24,254
23,204
26,622
Cost of revenue
9,453
9,927
9,213
9,865
9,293
Gross profit
17,633
19,042
15,041
13,339
17,329
Operating expenses
Research development
35,684
34,938
30,258
28,125
24,556
Selling general and administrative
58,358
63,048
50,038
48,804
67,072
Total operating expenses
94,042
97,986
80,296
76,929
91,628
Operating income or loss
-76,409
-78,944
-65,255
-63,590
-74,299
Interest expense
1,215
1,088
912
780
326
Income before tax
-74,186
-81,547
-63,840
-66,834
-74,247
Income tax expense
-6,446
-5,624
-6,727
-5,272
-4,605
Income from continuing operations
-67,740
-75,923
-57,113
-61,562
-69,642
Net income
-67,740
-75,923
-57,113
-61,562
-69,642
Net income available to common shareholders
-67,740
-75,923
-57,113
-61,562
-69,642
Basic EPS
-
-0.23
-0.20
-0.29
-0.39
Diluted EPS
-
-0.23
-0.20
-0.29
-0.39
Basic average shares
-
331,202
278,052
213,541
177,164
Diluted average shares
-
331,202
278,052
213,541
177,164
EBITDA
-
-76,493
-58,599
-62,060
-71,064